Literature DB >> 14992291

Pharmacological properties of glycine transport in the frog retina.

Jorge A Pérez-León1, Estuardo López-Vera, Rocío Salceda.   

Abstract

The high-affinity glycine transport in neurons and glial cells is the primary means for inactivating synaptic glycine. Two different glycine transporter genes, Glyt-1 and Glyt-2, have been cloned. Glyt-1 has been reported to occur in the retina, but there is no evidence for expression of the Glyt-2 transporter. We have pharmacologically characterized glycine transport in the frog retina. 3H-Glycine uptake in the retina was insensitive to modulation by phorbol esters or changes in cAMP levels, and was partially inhibited by sarcosine. Differential sensitivity of glycine transport to sarcosine was exhibited by synaptosomal fractions from the inner and outer plexiform layers of the frog retina. The Na+ Hill coefficient of glycine uptake was 2.0, as has been reported for Glyt-2. In addition, amoxapine, a specific inhibitor of the Glyt-2a isoform, reduced by 60% glycine uptake by P2 synaptosomal fraction. Our results indicate the presence of different glycine transporter isoforms in the frog retina, acting mainly through the classical inhibitory glycine system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14992291     DOI: 10.1023/b:nere.0000010460.34646.34

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  49 in total

Review 1.  Phosphorylation-dephosphorylation of enzymes.

Authors:  E G Krebs; J A Beavo
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

2.  Glycine transporters are differentially expressed among CNS cells.

Authors:  F Zafra; C Aragón; L Olivares; N C Danbolt; C Giménez; J Storm-Mathisen
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

3.  Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes.

Authors:  K M Kim; S F Kingsmore; H Han; T L Yang-Feng; N Godinot; M F Seldin; M G Caron; B Giros
Journal:  Mol Pharmacol       Date:  1994-04       Impact factor: 4.436

Review 4.  The glycine site of the NMDA receptor--five years on.

Authors:  J A Kemp; P D Leeson
Journal:  Trends Pharmacol Sci       Date:  1993-01       Impact factor: 14.819

5.  Localization of glycine neurotransmitter transporter (GLYT2) reveals correlation with the distribution of glycine receptor.

Authors:  F Jursky; N Nelson
Journal:  J Neurochem       Date:  1995-03       Impact factor: 5.372

Review 6.  Neurotransmitter transporters: new members of known families.

Authors:  P Schloss; A W Püschel; H Betz
Journal:  Curr Opin Cell Biol       Date:  1994-08       Impact factor: 8.382

7.  A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists.

Authors:  M Kessler; T Terramani; G Lynch; M Baudry
Journal:  J Neurochem       Date:  1989-04       Impact factor: 5.372

8.  Voltage- and transmitter-gated currents of all-amacrine cells in a slice preparation of the rat retina.

Authors:  R Boos; H Schneider; H Wässle
Journal:  J Neurosci       Date:  1993-07       Impact factor: 6.167

9.  Cloning, expression, and localization of a rat brain high-affinity glycine transporter.

Authors:  J Guastella; N Brecha; C Weigmann; H A Lester; N Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

10.  Glycine transport into plasma-membrane vesicles derived from rat brain synaptosomes.

Authors:  F Mayor; J G Marvizón; M C Aragón; C Gimenez; F Valdivieso
Journal:  Biochem J       Date:  1981-09-15       Impact factor: 3.857

View more
  1 in total

1.  Glycine transport accounts for the differential role of glycine vs. D-serine at NMDA receptor coagonist sites in the salamander retina.

Authors:  Eric R Stevens; Eric C Gustafson; Robert F Miller
Journal:  Eur J Neurosci       Date:  2010-03       Impact factor: 3.386

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.